Sign In
Buy ANIK
$14.41
+0.0300 (+0.209%)
At Close: Jun 03, 2026
Kirby McInerney LLP Announces Investigation Against Anika Therapeutics, Inc. (ANIK) on Behalf of Investors
04:42pm, Friday, 01'st Aug 2025
NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ:ANIK). The
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
06:45pm, Thursday, 31'st Jul 2025
NEW YORK , July 31, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ("Anika" or the "Company") (NASDAQ: ANIK). Such investors are advis
Anika Therapeutics, Inc. (ANIK) Q2 2025 Earnings Call Transcript
10:52am, Wednesday, 30'th Jul 2025
Anika Therapeutics, Inc. (NASDAQ:ANIK ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Cheryl Renee Blanchard - President, CEO & Director Matt Hall - Corporate Particip
Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates
09:15am, Wednesday, 30'th Jul 2025
Anika Therapeutics (ANIK) came out with a quarterly loss of $0.13 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.17 per share a year ago.
Anika Reports Second Quarter 2025 Financial Results
07:05am, Wednesday, 30'th Jul 2025
Regenerative Solutions revenue up 41% with Integrity ™ Implant System ahead of expectations and continued strong Hyalofast® growth; Integrity surpasses full year 2024 performance and is on pace to
Hyalofast consistently demonstrated improvements over microfracture, but missed on statistical significance of the pre-specified co-primary endpoints of percent change in KOOS Pain and IKDC function
Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025
04:01pm, Wednesday, 16'th Jul 2025
BEDFORD, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Thursday, 03'rd Jul 2025
BEDFORD, Mass., July 03, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early inte
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Thursday, 05'th Jun 2025
BEDFORD, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early inte
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Monday, 12'th May 2025
BEDFORD, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused o
Anika Therapeutics, Inc. (ANIK) Q1 2025 Earnings Call Transcript
11:51am, Friday, 09'th May 2025
Anika Therapeutics, Inc. (NASDAQ:ANIK ) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Matt Hall - Director, Corporate Development & Investor Relations Cheryl Blanchard -
Anika Therapeutics (ANIK) Reports Q1 Loss, Misses Revenue Estimates
09:35am, Friday, 09'th May 2025
Anika Therapeutics (ANIK) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of $0.09. This compares to loss of $0.31 per share a year ago.
Anika Reports First Quarter 2025 Financial Results
07:05am, Friday, 09'th May 2025
First Quarter 2025 Commercial Channel revenue up 18% Integrity ™ Implant System continues sequential growth and is on pace to more than double procedures in 2025 Key regulatory and clinical mileston
Anika to Participate in the Sidoti Virtual Investor Conference
04:01pm, Wednesday, 07'th May 2025
BEDFORD, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on
Is the Options Market Predicting a Spike in Anika Therapeutics Stock?
10:30am, Monday, 05'th May 2025
Investors need to pay close attention to ANIK stock based on the movements in the options market lately.
